Evaluation of effect of Ocimum basilicum L. (basil) and Plantago major on increased blood platelet

Evaluation of effect of Ocimum basilicum L. (basil) and Plantago major on increased blood platelet in ITP Patients

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190415043279N7

Enrollment

Registered

2020-09-14

Start date

2019-03-21

Completion date

Unknown

Last updated

2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immune thrombocytopenic purpura. Immune thrombocytopenic purpura

Interventions

Intervention 1: Intervention group: Capsule containing hydroalcoholic extract of Ocimum basilicum L. (basil) and Plantago major at dose of 400 mg three times a day for two consecutive months. These or

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Platelet count between 20,000 and 100,000 Do not take painkillers and corticosteroids

Exclusion criteria

Exclusion criteria: Lupus erythematosus Antiphospholipid syndrome CLL Infectious agents Recent bone marrow transplantation Pregnancy

Design outcomes

Primary

Measure	Time frame
Blood platelet count. Timepoint: Before intervention, one month after intervention, two months after intervention. Method of measurement: Complete blood count (CBC) test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBayazid Ghaderi

Sanandaj University of Medical Sciences

bayazid.g@yahoo.com+98 87 3366 4645

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026